- Home
- UBS vs SVA Comparison
UBS vs SVA Comparison
Compare UBS & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBS
- SVA
- Stock Information
- Founded
- UBS 1862
- SVA N/A
- Country
- UBS Switzerland
- SVA
- Employees
- UBS N/A
- SVA 3261
- Industry
- UBS Major Banks
- SVA
- Sector
- UBS Finance
- SVA
- Exchange
- UBS Nasdaq
- SVA NYSE
- Market Cap
- UBS N/A
- SVA N/A
- IPO Year
- UBS N/A
- SVA N/A
- Fundamental
- Price
- UBS $31.89
- SVA $6.47
- Analyst Decision
- UBS Hold
- SVA
- Analyst Count
- UBS 2
- SVA 0
- Target Price
- UBS N/A
- SVA N/A
- AVG Volume (30 Days)
- UBS 3.1M
- SVA N/A
- Earning Date
- UBS 04-30-2025
- SVA N/A
- Dividend Yield
- UBS 2.80%
- SVA N/A
- EPS Growth
- UBS N/A
- SVA N/A
- EPS
- UBS 1.51
- SVA N/A
- Revenue
- UBS $47,760,000,000.00
- SVA N/A
- Revenue This Year
- UBS $1.11
- SVA N/A
- Revenue Next Year
- UBS $2.42
- SVA N/A
- P/E Ratio
- UBS $19.44
- SVA N/A
- Revenue Growth
- UBS 9.69
- SVA N/A
- 52 Week Low
- UBS $25.75
- SVA N/A
- 52 Week High
- UBS $35.84
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- UBS 53.46
- SVA N/A
- Support Level
- UBS $31.50
- SVA N/A
- Resistance Level
- UBS $32.10
- SVA N/A
- Average True Range (ATR)
- UBS 0.39
- SVA 0.00
- MACD
- UBS -0.13
- SVA 0.00
- Stochastic Oscillator
- UBS 16.88
- SVA 0.00
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.